Article
G&L growth continues with two strategic appointments
Posted on the 9th January 2024
G&L Healthcare Advisors continues its commitment to innovation, excellence, and global growth with the recent additions of Bill Griffiths and Eric Shobe to its Leadership Team.
Bill joins as Chief Regulatory Affairs Officer, bringing nearly four decades of globally recognized expertise in regulatory affairs, with pivotal roles at Sandoz, GSK, Abbott, and Novartis.
His wealth of knowledge and strategic insights underscore G&L's dedication to setting the standard in healthcare consultancy.
As Chief Commercial Officer, Eric contributes unparalleled innovation and influence in global research and development procurement.
With a distinguished career spanning decades at industry giants such as Novartis, Pfizer, and Pharmacia Cooperation, Eric boasts extensive experience in both Research and Development and Business Operations.
His remarkable track record includes contributions to three NDA approvals, integration of six major M&As, and leading initiatives optimizing the ROI of R&D.
The strategic combination of Eric's innovative approach and Bill's regulatory expertise solidifies G&L's commitment to excellence.
As integral members of the G&L Executive Team and Board, Bill and Eric will play pivotal roles in shaping and executing strategic plans for sustained growth and development.
Their alignment with the company marks a significant milestone, reaffirming G&L's dedication to attracting top-tier talent in the industry.
Since its founding in 2016 by Peter Griffin and Stephen Loughrey, G&L Healthcare Advisors has emerged as one of the world’s fastest-growing and most innovative healthcare consultancy firms, renowned for groundbreaking approaches to specific services and solutions.